Annual Secretarial Compliance Report for the Year ended March 31, 2025
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has submitted its Annual Secretarial Compliance Report for FY25 to NSE and BSE, as required under Regulation 24A of SEBI's Listing Rules. The report, issued by practising company secretary V. Bhaskara Rao and Co., confirms that the company complied with all applicable SEBI regulations, the SEBI Act, SCRA, and Depositories Act during the review period. The company also adhered to Secretarial Standards 1, 2, and 3 (the last voluntarily, relating to dividends), maintained a functional website with timely disclosures, and preserved records as per its policy. No director was found disqualified under Section 164 of the Companies Act, 2013, and related party transactions received prior audit committee approval. Importantly, no action was taken against the company, its promoters, directors, or subsidiaries by SEBI or the stock exchanges during the year, and no non-compliance was flagged.
This is a routine annual compliance filing with no negative findings — shareholders can take it as a clean bill of regulatory health. No material impact on stock price is expected; it simply reinforces that the company maintains strong governance and disclosure standards.